共 50 条
- [41] Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature reviewBRITISH JOURNAL OF HAEMATOLOGY, 2019, 184 (02) : 134 - 160Park, Sophie论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, France Ctr Hosp Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, FranceGreenberg, Peter论文数: 0 引用数: 0 h-index: 0机构: Stanford Univ, Canc Ctr, Stanford, CA 94305 USA Ctr Hosp Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, FranceYucel, Aylin论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA 91320 USA Ctr Hosp Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, FranceFarmer, Caroline论文数: 0 引用数: 0 h-index: 0机构: Parametr Solut Inc, London, England Ctr Hosp Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, FranceO'Neill, Frank论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA 91320 USA Ctr Hosp Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, FranceBrandao, Cisio De Oliveira论文数: 0 引用数: 0 h-index: 0机构: Amgen Inc, Thousand Oaks, CA 91320 USA Ctr Hosp Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, FranceFenaux, Pierre论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, Serv Hematol Clin, Paris, France Paris 7 Univ, Paris, France Ctr Hosp Univ Grenoble Alpes, Clin Univ Hematol, Grenoble, France
- [42] Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysisLEUKEMIA, 2013, 27 (05) : 1072 - 1079Kuendgen, A.论文数: 0 引用数: 0 h-index: 0机构: Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyLauseker, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Munich, Inst Med Informat Sci Biometry & Epidemiol, Munich, Germany Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyList, A. F.论文数: 0 引用数: 0 h-index: 0机构: Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyFenaux, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Paris 13, Hop Avicenne, Assistance Publ Hop Paris, Grp Francophone Myelodysplasies, Bobigny, France Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyGiagounidis, A. A.论文数: 0 引用数: 0 h-index: 0机构: Marienhospital, Dept Hematol Oncol & Palliat Care, Dusseldorf, Germany Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyBrandenburg, N. A.论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ USA Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyBackstrom, J.论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ USA Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyGlasmacher, A.论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Summit, NJ USA Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyHasford, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Munich, Inst Med Informat Sci Biometry & Epidemiol, Munich, Germany Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, GermanyGerming, U.论文数: 0 引用数: 0 h-index: 0机构: Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany Heinrich Heine Univ Hosp, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany
- [43] Lenalidomide does not increase AML progression risk in RBC transfusion-dependent patients with Low- or Intermediate-1-risk MDS with del(5q): a comparative analysisLeukemia, 2013, 27 : 1072 - 1079A Kuendgen论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyM Lauseker论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyA F List论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyP Fenaux论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyA A Giagounidis论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyN A Brandenburg论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyJ Backstrom论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyA Glasmacher论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyJ Hasford论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of HematologyU Germing论文数: 0 引用数: 0 h-index: 0机构: Oncology and Clinical Immunology,Department of Hematology
- [44] A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndromeHAEMATOLOGICA, 2022, 107 (11) : 2742 - 2747Komrokji, Rami S.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USACarraway, Hetty E.论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAGerming, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Heinrich Heine Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Univ Klinikum, Dusseldorf, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAWermke, Martin论文数: 0 引用数: 0 h-index: 0机构: Tech Univ, Med Fac Carl Gustav Carus, NCT UCC ECTU, Dresden, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAZeidan, Amer M.论文数: 0 引用数: 0 h-index: 0机构: Yale Univ, Sch Med, Dept Internal Med, Sect Hematol, New Haven, CT 06510 USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAFu, Eric论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USARueter, Bjoern论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USABurkard, Ute论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAOsswald, Annika论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Biberach, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAForan, James M.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Dept Hematol & Med Oncol, Jacksonville, FL 32224 USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USA
- [45] A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndromeHAEMATOLOGICA, 2022, 107 : 2742 - 2747Komrokji, Rami S.论文数: 0 引用数: 0 h-index: 0机构: H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USACarraway, Hetty E.论文数: 0 引用数: 0 h-index: 0机构: Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAGerming, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Heinrich Heine Univ Dusseldorf, Univ Klinikum Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAWermke, Martin论文数: 0 引用数: 0 h-index: 0机构: Tech Univ, Med Fac Carl Gustav Carus, NCT UCC ECTU, Dresden, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAZeidan, Amer M.论文数: 0 引用数: 0 h-index: 0机构: Yale Univ, Sch Med, Dept Internal Med, Sect Hematol, New Haven, CT USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAFu, Eric论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USARueter, Bjoern论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharm GmbH & Co KG, Biberach, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USABurkard, Ute论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharm GmbH & Co KG, Biberach, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAOsswald, Annika论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharm GmbH & Co KG, Biberach, Germany H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USAForan, James M.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Dept Hematol & Med Oncol, Jacksonville, FL USA H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL 33612 USA
- [46] LENALIDOMIDE THERAPY IN MYELODYSPLASTIC SYNDROMES WITH LOW-OR-INTERMEDIATE-1 IPSS RISK AND DEL(5Q): RETROSPECTIVE STUDY OF 17 PATIENTS FROM A SINGLE INSTITUTIONHAEMATOLOGICA, 2016, 101 : S119 - S119Finelli, C.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyFollo, M. Y.论文数: 0 引用数: 0 h-index: 0机构: Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyBarraco, M.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyDe Maio, C.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyTestoni, N.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyOttaviani, E.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyParisi, S.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyMongiorgi, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyStanzani, M.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyPapayannidis, C.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyCocco, L.论文数: 0 引用数: 0 h-index: 0机构: Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, ItalyCavo, M.论文数: 0 引用数: 0 h-index: 0机构: S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy S Orsola Malpighi Univ Hosp, Hematol, Bologna, Italy
- [47] Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromesAMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (04) : E111 - E114Garcia-Manero, Guillermo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USADiez-Campelo, Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Salamanca, Hosp Clin, Salamanca, Spain Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAVellenga, Edo论文数: 0 引用数: 0 h-index: 0机构: Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJacoby, Meagan A.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ, Sch Med, St Louis, MO USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAMerchan, Brayan论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona, Spain Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABreems, Dimitri论文数: 0 引用数: 0 h-index: 0机构: Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USACortelezzi, Agostino论文数: 0 引用数: 0 h-index: 0机构: Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy Univ Milan, Milan, Italy Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USADoronin, Vadim论文数: 0 引用数: 0 h-index: 0机构: City Clin Hosp 40, Moscow, Russia Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAGomez, Valle论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ La Princesa, Madrid, Spain Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABeckers, Marielle论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Leuven, Belgium Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USADella Porta, Matteo Giovanni论文数: 0 引用数: 0 h-index: 0机构: Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Rozzano, Italy Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAVarsos, Helen论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAXiu, Liang论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USADeAngelis, Nikki论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USANnane, Ivo论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Spring House, PA USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USARose, Esther论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev LLC, Raritan, NJ USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAvan Eygen, Koen论文数: 0 引用数: 0 h-index: 0机构: AZ Groeninge, Kortrijk, Belgium Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [48] p53 protein expression predicts outcome and cytogenetic response in patients with low-/INT-1-risk myelodysplastic syndromes treated with lenalidomideLEUKEMIA RESEARCH, 2013, 37 : S66 - S66Saft, L.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Dept Pathol Cytol, Stockholm, Sweden Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenKarimi, M.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Ctr Hematol & Regenerat Med, Stockholm, Sweden Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenGhaderi, M.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Univ, Hosp Solna, Mol Pathol, Stockholm, Sweden Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenMatolscy, A.论文数: 0 引用数: 0 h-index: 0机构: Semmelweis Univ, Pathol & Expt Canc Res, H-1085 Budapest, Hungary Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenFenaux, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Parix XIII Bobigny, Hop Avicenne, Paris, France Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenMufti, G.论文数: 0 引用数: 0 h-index: 0机构: Kings Coll Hosp London, Hematol, London, England Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenGiagounidis, A.论文数: 0 引用数: 0 h-index: 0机构: St Johannes Hosp, Med, Duisburg, Germany Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenSelleslag, D.论文数: 0 引用数: 0 h-index: 0机构: AZ St Jan Brugge AV, Med, Brugge, Belgium Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenMuus, P.论文数: 0 引用数: 0 h-index: 0机构: Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenSanz, G.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ La Fe, Med, Valencia, Spain Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenMittelman, M.论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Med Ctr, IL-69978 Tel Aviv, Israel Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenBowen, D.论文数: 0 引用数: 0 h-index: 0机构: St Jamess Inst Oncol, Oncol, Leeds, W Yorkshire, England Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenPorwit, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Hlth Network, Lab Med & Pathobiol, Toronto, ON, Canada Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenFu, T.论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Celgene, Summit, NJ USA Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenBackstrom, J.论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Celgene, Summit, NJ USA Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenMacBeth, K.论文数: 0 引用数: 0 h-index: 0机构: Celgene Corp, Celgene, Summit, NJ USA Karolinska Inst, Dept Pathol Cytol, Stockholm, SwedenHellstrom-Lindberg, E.论文数: 0 引用数: 0 h-index: 0机构: Karolinska Inst, Med Ctr Hematol & Regenerat Med, Huddinge, Sweden Karolinska Inst, Dept Pathol Cytol, Stockholm, Sweden
- [49] Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical TrialCLINICAL CANCER RESEARCH, 2023, 29 (01) : 60 - 66Gonzalez-Lugo, Jesus D.论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAKambhampati, Suman论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Transplant & Cellular Therapy Program, Kansas City, KS USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAYacoub, Abdulraheem论文数: 0 引用数: 0 h-index: 0机构: Univ Kansas, Canc Ctr, Westwood, KS USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USADonnellan, William B.论文数: 0 引用数: 0 h-index: 0机构: Tennessee Oncol, Chattanooga, TN USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USABerdeja, Jesus论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USABhagat, Prafulla论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAFehn, Karen论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USARemy, Cassady论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAJasra, Sakshi论文数: 0 引用数: 0 h-index: 0机构: Univ Vermont, Canc Ctr, Burlington, VT USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAKazemi, Mohammed论文数: 0 引用数: 0 h-index: 0机构: Astera Canc Care, East Brunswick, NJ USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAPradhan, Kith论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAKim, Mimi论文数: 0 引用数: 0 h-index: 0机构: Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAMantzaris, Ioannis论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USASica, R. Alejandro论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAShah, Nishi论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAGoldfinger, Mendel论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAKornblum, Noah论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAGritsman, Kira论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USABraunschweig, Ira论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USASteidl, Ulrich论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAWill, Britta论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAShastri, Aditi论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USAVerma, Amit论文数: 0 引用数: 0 h-index: 0机构: Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA 1300 Morris Pk Ave, Bronx, NY 10461 USA Montefiore Einstein Canc Ctr, Blood Canc Inst, Dept Oncol, Div Hematooncol, Bronx, NY 10461 USA
- [50] A Prospective Multicenter Open-Label Study of the Effectiveness of Epoetin Beta for Patients with Low/Intermediate-1-Risk Myelodysplastic Syndrome (MDS): A Preliminary ResultBLOOD, 2016, 128 (22)Chuncharunee, Suporn论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandKanitsap, Nonglak论文数: 0 引用数: 0 h-index: 0机构: Thammasat Univ, Dept Internal Med, Pathum Thani, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandSuwanban, Tawatchai论文数: 0 引用数: 0 h-index: 0机构: Rajavithi Hosp, Dept Internal Med, Bangkok, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandKhuhapinant, Archrob论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Dept Med, Bangkok, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandUaprasert, Noppacharn论文数: 0 引用数: 0 h-index: 0机构: Chulalongkorn Univ, Dept Med, Bangkok, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandChansung, Kanchana论文数: 0 引用数: 0 h-index: 0机构: Khon Kaen Univ, Dept Internal Med, Khon Kaen, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandRattarittamrong, Ekarat论文数: 0 引用数: 0 h-index: 0机构: Chiang Mai Univ, Dept Internal Med, Chiang Mai, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandWongkhantee, Somchai论文数: 0 引用数: 0 h-index: 0机构: Khonkaen Reg Hosp, Dept Internal Med, Khon Kaen, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandSiritanaratanakul, Noppadol论文数: 0 引用数: 0 h-index: 0机构: Mahidol Univ, Siriraj Hosp, Dept Med, Bangkok, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandNorasetthada, Lalita论文数: 0 引用数: 0 h-index: 0机构: Chiang Mai Univ, Dept Internal Med, Chiang Mai, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandNakorn, Thanyaphong Na论文数: 0 引用数: 0 h-index: 0机构: Chulalongkorn Univ, Dept Med, Bangkok, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, ThailandCharnwiboonsri, Chadchai论文数: 0 引用数: 0 h-index: 0机构: Roche Thailand Ltd, Med Dept, Bangkok, Thailand Mahidol Univ, Ramathibodi Hosp, Dept Internal Med, Bangkok, Thailand